EXAS logo

Exact Sciences Corporation (EXAS)

Profile

Full Name

Exact Sciences Corporation

Ticker

NASDAQ: EXAS

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

February 1, 2001

Indexes

Not included

Website

http://www.exactsciences.com

Employees

6900

Key Details

Price

$51.91(-2.64%)

Market cap

$9.79B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.76B(+10.37% YoY)

Annual EPS

-$5.59(-394.69% YoY)

PE ratio

-

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $51.91
    EXAS price is $51.91

    30-Day Relative Volume

    0.56
    EXAS 30-day relative volume is 0.56

    Price Performance

    Price Most recent change

    -2.64%
    EXAS price was down -2.64% on Jul 11, 2025

    Price YTD change

    -7.62%
    EXAS price is down -7.62% since January 1st

    Price 1-year change

    +15.77%
    EXAS price is up +15.77% year-on-year

    Price 3-year change

    +14.39%
    EXAS price is up +14.39% over the past 3 years

    Price Range

    Price All-time high

    $159.54
    EXAS price is currently -67.46% below its historical high of $159.54

    Price 3-year low

    $29.27
    EXAS price is currently +77.35% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.79B
    EXAS market capitalization is $9.79 billion

    Market cap 3-year change

    +22.05%
    EXAS market capitalization is up +22.05% over the past 3 years

    Market cap All-time high

    $26.21B
    EXAS market capitalization is currently -62.64% below its historical high of $26.21 billion

    Market cap sector rank

    92.23%
    EXAS market capitalization is higher than 92.23% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.15%
    EXAS shares outstanding is up +2.15% year-on-year

    Shares Outstanding 3-Year Change

    +6.69%
    EXAS shares outstanding is up +6.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.72
    EXAS beta is 0.72

    200-day SMA

    $55.04
    EXAS price is currently -5.68% below its 200-day simple moving average

    50-day SMA

    $54.02
    EXAS price is currently -3.91% below its 50-day simple moving average

    RSI

    44.34
    EXAS 14-day relative strength index is 44.34

    Volume

    0.56
    EXAS 30-day relative volume is 0.56

    ATR

    $2.27
    EXAS average true range is $2.27

    10-day Historical Volatility

    41.48%
    EXAS 10-day historical volatility is 41.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.76B
    EXAS annual revenue is $2.76 billion

    Revenue Analysts estimate

    $3.10B
    EXAS annual revenue is currently -10.88% lower than the consensus analysts' forecast

    Revenue 1-year change

    +10.37%
    EXAS annual revenue is up +10.37% year-on-year

    Revenue Sector rank

    87.4%
    EXAS annual revenue is higher than 87.4% of companies in Healthcare sector

    EPS

    EPS

    -$5.59
    EXAS annual earnings per share is -$5.59

    EPS Analysts estimate

    $0.21
    EXAS annual earnings per share is currently -2805.71% lower than the consensus analysts' forecast

    EPS 1-year change

    -394.69%
    EXAS annual earnings per share is down -394.69% year-on-year

    EPS Sector rank

    18.64%
    EXAS annual earnings per share is higher than 18.64% of companies in Healthcare sector

    Profit

    Gross profit

    $1.92B
    EXAS annual gross profit is $1.92 billion

    Gross margin

    69.55%
    EXAS annual gross profit margin is 69.55%

    Operating profit

    -$179.14M
    EXAS annual operating income is -$179.14 million

    Operating margin

    -6.49%
    EXAS annual operating profit margin is -6.49%

    Net income

    -$1.03B
    EXAS annual net profit is -$1.03 billion

    Net margin

    -37.29%
    EXAS annual net profit margin is -37.29%

    Expenses

    Total expenses

    $2.94B
    EXAS annual total expenses is $2.94 billion

    Operating expenses

    $2.10B
    EXAS annual total operating expenses is $2.10 billion

    Cost of goods sold

    $840.20M
    EXAS annual cost of goods sold is $840.20 million

    Selling, general & administrative expenses

    $1.67B
    EXAS annual SGA is $1.67 billion

    Depreciation and amortization

    $214.86M
    EXAS annual depreciation & amortization is $214.86 million

    Interest expense

    $31.97M
    EXAS annual interest expense is $31.97 million

    Income tax

    -$7.30M
    EXAS annual income tax is -$7.30 million

    EBIT & EBITDA

    EBIT

    -$1.00B
    EXAS annual earnings before interest & taxes is -$1.00 billion

    EBITDA

    -$789.33M
    EXAS annual EBITDA is -$789.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.93B
    EXAS annual total assets is $5.93 billion

    Non current assets

    $4.36B
    EXAS annual long term assets is $4.36 billion

    Current assets

    $1.57B
    EXAS annual total current assets is $1.57 billion

    Cash and cash equivalents

    $600.89M
    EXAS annual cash & cash equivalents is $600.89 million

    Accounts receivable

    $248.97M
    EXAS annual accounts receivable is $248.97 million

    Inventory

    $162.38M
    EXAS annual inventory is $162.38 million

    Liabilities

    Total liabilities

    $3.53B
    EXAS annual total liabilities is $3.53 billion

    Long term liabilities

    $2.79B
    EXAS annual total long term liabilities is $2.79 billion

    Current liabilities

    $732.19M
    EXAS annual total current liabilities is $732.19 million

    Accounts payable

    $89.57M
    EXAS annual accounts payable is $89.57 million

    Debt

    Total debt

    $2.75B
    EXAS annual total debt is $2.75 billion

    Total debt 1-year change

    +7.83%
    EXAS annual total debt is up +7.83% year-on-year

    Long term debt

    $2.48B
    EXAS annual long term debt is $2.48 billion

    Short term debt

    $276.56M
    EXAS annual short term debt is $276.56 million

    Equity & Capital

    Shareholders equity

    $2.40B
    EXAS annual stockholders equity is $2.40 billion

    Book value

    $2.40B
    EXAS annual book value is $2.40 billion

    Retained earnings

    -$4.50B
    EXAS annual retained earnings is -$4.50 billion

    Working capital

    $839.24M
    EXAS annual working capital is $839.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $210.54M
    EXAS annual cash flow from operations is $210.54 million

    Cash from operations 1-year change

    +34.86%
    EXAS annual cash flow from operations is up +34.86% year-on-year

    Cash from investing

    -$442.15M
    EXAS annual cash flow from investing activities is -$442.15 million

    Cash from investing 1-year change

    -990.02%
    EXAS annual cash flow from investing activities is down -990.02% year-on-year

    Cash from financing

    $231.87M
    EXAS annual cash flow from financing activities is $231.87 million

    Cash from financing 1-year change

    +45.13%
    EXAS annual cash flow from financing activities is up +45.13% year-on-year

    CAPEX

    CAPEX

    $135.99M
    EXAS annual capital expenditures is $135.99 million

    CAPEX 1-year change

    +9.5%
    EXAS annual capital expenditures is up +9.5% year-on-year

    Free Cash Flow

    Free cash flow

    $74.55M
    EXAS annual free cash flow is $74.55 million

    Free cash flow 1-year change

    +133.48%
    EXAS annual free cash flow is up +133.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.55%
    EXAS annual gross profit margin is 69.55%

    Operating margin

    -6.49%
    EXAS annual operating profit margin is -6.49%

    Net margin

    -37.29%
    EXAS annual net profit margin is -37.29%

    ROA & ROE

    ROA

    -16.60%
    EXAS annual return on assets is -16.60%

    ROE

    -37.09%
    EXAS annual return on equity is -37.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    EXAS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    EXAS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.09
    EXAS price to book ratio is 4.09

    PB ratio Sector rank

    75.1%
    EXAS price to book ratio is higher than 75.1% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.46
    EXAS price to sales ratio is 3.46

    PS ratio Sector rank

    53.49%
    EXAS price to sales ratio is higher than 53.49% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $11.97B
    EXAS enterprise value is $11.97 billion

    Enterprise value Sector rank

    92.67%
    EXAS enterprise value is higher than 92.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -15.11
    EXAS EV/EBITDA is -15.11

    EV/EBITDA Sector rank

    9.94%
    EXAS EV/EBITDA is higher than 9.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.15
    EXAS annual current ratio is 2.15

    Quick ratio

    1.92
    EXAS annual quick ratio is 1.92

    Leverage

    Debt to equity

    1.07
    EXAS annual debt to equity ratio is 1.07

    Interest coverage ratio

    -31.41
    EXAS annual interest coverage ratio is -31.41

    Risk & Stability

    Piotroski F-Score

    5
    EXAS piotroski f-score is 5

    Altman Z-Score

    0.68
    EXAS altman z-score is 0.68

    Analyst ratings

    Recent major analysts updates

    Jun 24, 25 Barclays
    Overweight
    May 2, 25 RBC Capital
    Sector Perform
    May 2, 25 Evercore ISI Group
    Outperform
    May 2, 25 Barclays
    Overweight
    May 2, 25 Baird
    Outperform
    Apr 11, 25 Guggenheim
    Buy
    Apr 10, 25 Mizuho
    Outperform
    Apr 10, 25 Barclays
    Overweight
    Mar 13, 25 RBC Capital
    Sector Perform
    Feb 26, 25 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with EXAS included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Exact Sciences Corporation?
    • Does Exact Sciences Corporation pay dividends?
    • What sector is Exact Sciences Corporation in?
    • What industry is Exact Sciences Corporation in?
    • What country is Exact Sciences Corporation based in?
    • When did Exact Sciences Corporation go public?
    • Is Exact Sciences Corporation in the S&P 500?
    • Is Exact Sciences Corporation in the NASDAQ 100?
    • Is Exact Sciences Corporation in the Dow Jones?
    • When was Exact Sciences Corporation's last earnings report?
    • When does Exact Sciences Corporation report earnings?

    What is the ticker symbol for Exact Sciences Corporation?

    The ticker symbol for Exact Sciences Corporation is NASDAQ:EXAS

    Does Exact Sciences Corporation pay dividends?

    No, Exact Sciences Corporation does not pay dividends

    What sector is Exact Sciences Corporation in?

    Exact Sciences Corporation is in the Healthcare sector

    What industry is Exact Sciences Corporation in?

    Exact Sciences Corporation is in the Diagnostics & Research industry

    What country is Exact Sciences Corporation based in?

    Exact Sciences Corporation is headquartered in United States

    When did Exact Sciences Corporation go public?

    Exact Sciences Corporation's initial public offering (IPO) was on February 1, 2001

    Is Exact Sciences Corporation in the S&P 500?

    No, Exact Sciences Corporation is not included in the S&P 500 index

    Is Exact Sciences Corporation in the NASDAQ 100?

    No, Exact Sciences Corporation is not included in the NASDAQ 100 index

    Is Exact Sciences Corporation in the Dow Jones?

    No, Exact Sciences Corporation is not included in the Dow Jones index

    When was Exact Sciences Corporation's last earnings report?

    Exact Sciences Corporation's most recent earnings report was on May 1, 2025

    When does Exact Sciences Corporation report earnings?

    The next expected earnings date for Exact Sciences Corporation is July 31, 2025
    On this page